192 related articles for article (PubMed ID: 27609595)
21. The impact of highly active antiretroviral therapy on the survival of vertically HIV-infected children and adolescents in Belo Horizonte, Brazil.
Cardoso CA; Pinto JA; Candiani TM; Carvalho IR; Linhares RM; Goulart EM
Mem Inst Oswaldo Cruz; 2012 Jun; 107(4):532-8. PubMed ID: 22666865
[TBL] [Abstract][Full Text] [Related]
22. Determinants and causes of mortality in HIV-infected patients receiving antiretroviral therapy in Burkina Faso: a five-year retrospective cohort study.
Kouanda S; Meda IB; Nikiema L; Tiendrebeogo S; Doulougou B; Kaboré I; Sanou MJ; Greenwell F; Soudré R; Sondo B
AIDS Care; 2012; 24(4):478-90. PubMed ID: 22148973
[TBL] [Abstract][Full Text] [Related]
23. Highly active antiretroviral therapy and survival in HIV-infected injection drug users.
Wood E; Hogg RS; Lima VD; Kerr T; Yip B; Marshall BD; Montaner JS
JAMA; 2008 Aug; 300(5):550-4. PubMed ID: 18677027
[TBL] [Abstract][Full Text] [Related]
24. Mortality and its determinants in antiretroviral treatment-naive HIV-infected children with suspected tuberculosis: an observational cohort study.
Marcy O; Tejiokem M; Msellati P; Truong Huu K; Do Chau V; Tran Ngoc D; Nacro B; Ateba-Ndongo F; Tetang-Ndiang S; Ung V; Dim B; Neou L; Berteloot L; Borand L; Delacourt C; Blanche S;
Lancet HIV; 2018 Feb; 5(2):e87-e95. PubMed ID: 29174612
[TBL] [Abstract][Full Text] [Related]
25. Initial experience of a public sector antiretroviral treatment programme for HIV-infected children and their infected parents.
Eley B; Nuttall J; Davies MA; Smith L; Cowburn C; Buys H; Hussey G
S Afr Med J; 2004 Aug; 94(8):643-6. PubMed ID: 15352588
[TBL] [Abstract][Full Text] [Related]
26. Simultaneous HAART improves survival in children coinfected with HIV and TB.
Pensi T; Hemal A; Banerjee T
Trop Med Int Health; 2012 Jan; 17(1):52-8. PubMed ID: 21967134
[TBL] [Abstract][Full Text] [Related]
27. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy.
Bouhnik AD; Préau M; Vincent E; Carrieri MP; Gallais H; Lepeu G; Gastaut JA; Moatti JP; Spire B;
Antivir Ther; 2005; 10(1):53-61. PubMed ID: 15751763
[TBL] [Abstract][Full Text] [Related]
28. Mortality trends in the US Perinatal AIDS Collaborative Transmission Study (1986-2004).
Kapogiannis BG; Soe MM; Nesheim SR; Abrams EJ; Carter RJ; Farley J; Palumbo P; Koenig LJ; Bulterys M
Clin Infect Dis; 2011 Nov; 53(10):1024-34. PubMed ID: 22002982
[TBL] [Abstract][Full Text] [Related]
29. Predictors of early death in a cohort of Ethiopian patients treated with HAART.
Jerene D; Endale A; Hailu Y; Lindtjørn B
BMC Infect Dis; 2006 Sep; 6():136. PubMed ID: 16948852
[TBL] [Abstract][Full Text] [Related]
30. Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia.
Bolton-Moore C; Mubiana-Mbewe M; Cantrell RA; Chintu N; Stringer EM; Chi BH; Sinkala M; Kankasa C; Wilson CM; Wilfert CM; Mwango A; Levy J; Abrams EJ; Bulterys M; Stringer JS
JAMA; 2007 Oct; 298(16):1888-99. PubMed ID: 17954540
[TBL] [Abstract][Full Text] [Related]
31. Health-related quality of life and survival among HIV-infected patients receiving highly active antiretroviral therapy: a study of patients in the AIDS Therapy Evaluation in the Netherlands (ATHENA) Cohort.
de Boer-van der Kolk IM; Sprangers MA; Prins JM; Smit C; de Wolf F; Nieuwkerk PT
Clin Infect Dis; 2010 Jan; 50(2):255-63. PubMed ID: 20014949
[TBL] [Abstract][Full Text] [Related]
32. Virological control during the first 6-18 months after initiating highly active antiretroviral therapy as a predictor for outcome in HIV-infected patients: a Danish, population-based, 6-year follow-up study.
Lohse N; Kronborg G; Gerstoft J; Larsen CS; Pedersen G; Pedersen C; Sørensen HT; Obel N
Clin Infect Dis; 2006 Jan; 42(1):136-44. PubMed ID: 16323104
[TBL] [Abstract][Full Text] [Related]
33. The effect of highly active antiretroviral therapy on the survival of HIV-infected children in a resource-deprived setting: a cohort study.
Edmonds A; Yotebieng M; Lusiama J; Matumona Y; Kitetele F; Napravnik S; Cole SR; Van Rie A; Behets F
PLoS Med; 2011 Jun; 8(6):e1001044. PubMed ID: 21695087
[TBL] [Abstract][Full Text] [Related]
34. Survival and predictors of mortality among human immunodeficiency virus patients on anti-retroviral treatment at Jinka Hospital, South Omo, Ethiopia: a six years retrospective cohort study.
Tachbele E; Ameni G
Epidemiol Health; 2016; 38():e2016049. PubMed ID: 27820957
[TBL] [Abstract][Full Text] [Related]
35. HIV-related mortality in Jamaican children.
Evans-Gilbert T; Pierre RB; Steel-Duncan J; Palmer P; Figueroa JP; Christie CD
West Indian Med J; 2008 Jun; 57(3):265-8. PubMed ID: 19583126
[TBL] [Abstract][Full Text] [Related]
36. [Determinants of survival of HIV-infected children aged 6 months to 15 years on follow-up in the town of Ebolowa, Cameroon from 2008 to 2018].
Kalla GCM; Mve VM; Noubi NK; Mandeng MNE; Assoumou MCO; Mbopi-Keou FX; Monebenimp F
Pan Afr Med J; 2020; 37():308. PubMed ID: 33654527
[TBL] [Abstract][Full Text] [Related]
37. Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study.
Etard JF; Ndiaye I; Thierry-Mieg M; Guèye NF; Guèye PM; Lanièce I; Dieng AB; Diouf A; Laurent C; Mboup S; Sow PS; Delaporte E
AIDS; 2006 May; 20(8):1181-9. PubMed ID: 16691070
[TBL] [Abstract][Full Text] [Related]
38. Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era.
Brady MT; Oleske JM; Williams PL; Elgie C; Mofenson LM; Dankner WM; Van Dyke RB;
J Acquir Immune Defic Syndr; 2010 Jan; 53(1):86-94. PubMed ID: 20035164
[TBL] [Abstract][Full Text] [Related]
39. Mortality rate among HIV-positive children on ART in Northwest Ethiopia: a historical cohort study.
Alebel A; Engeda EH; Kelkay MM; Petrucka P; Kibret GD; Wagnew F; Asmare G; Bitew ZW; Ketema DB; Gedif G; Temesgen B; Hibstie YT; Melkamu MW; Eshetie S
BMC Public Health; 2020 Aug; 20(1):1303. PubMed ID: 32854692
[TBL] [Abstract][Full Text] [Related]
40. Opportunistic infections and organ-specific diseases in HIV-1-infected children: a cohort study (1990-2006).
Guillén S; García San Miguel L; Resino S; Bellón JM; González I; Jiménez de Ory S; Muñoz-Fernández MA; Navarro ML; Gurbindo MD; de José MI; Mellado MJ; Martín-Fontelos P; Gonzalez-Tomé MI; Martinez J; Beceiro J; Roa MA; Ramos JT;
HIV Med; 2010 Apr; 11(4):245-52. PubMed ID: 20050937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
